Osaic Holdings’s Alterity Therapeutics ATHE Stock Holding History
Bought
Maintained
Sold
Other funds holding ATHE
PFGI
Osaic Holdings's ATHE Position: Q3 2026 in Review
Osaic Holdings held its Alterity Therapeutics (ATHE) position steady in Q3 2026 at 68 shares worth $246. The position accounts for ﹤0.01% of the portfolio, ranked #7826.
Osaic Holdings first reported a position in ATHE in Q1 2020 and has held it in 27 quarters since. The position peaked at $889 in Q3 2025. 22 funds tracked by Wall St. Rank hold ATHE as of Q3 2026.
- Osaic Holdings held 68 shares of Alterity Therapeutics worth $246 as of Q3 2026.
- Osaic Holdings left its Alterity Therapeutics share count unchanged in Q3 2026.
- Alterity Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7826 holding.
- Osaic Holdings first reported a position in Alterity Therapeutics in Q1 2020 and has held it in 27 quarters since.
- Osaic Holdings's Alterity Therapeutics position peaked at $889 in Q3 2025.
- 22 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.